Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Xeris Pharmaceuticals stock
Learn how to easily invest in Xeris Pharmaceuticals stock.
Xeris Pharmaceuticals Inc is a biotechnology business based in the US. Xeris Pharmaceuticals shares (XERS) are listed on the NASDAQ and all prices are listed in US Dollars. Xeris Pharmaceuticals employs 294 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Xeris Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – XERS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Xeris Pharmaceuticals stock price (NASDAQ: XERS)Use our graph to track the performance of XERS stocks over time.
Xeris Pharmaceuticals shares at a glance
|Latest market close||$1.50|
|52-week range||$1.25 - $4.21|
|50-day moving average||$2.01|
|200-day moving average||$2.25|
|Wall St. target price||$6.10|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.42|
Buy Xeris Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Xeris Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Xeris Pharmaceuticals price performance over time
|1 week (2022-06-27)||-6.83%|
|1 month (2022-06-03)||-31.82%|
|3 months (2022-04-04)||-43.18%|
|6 months (2022-01-04)||-42.53%|
|1 year (2021-07-02)||-64.71%|
|2 years (2020-07-02)||-46.24%|
|3 years (2019-07-03)||11.73|
|5 years (2017-06-30)||N/A|
Xeris Pharmaceuticals financials
|Revenue TTM||$63.5 million|
|Gross profit TTM||$36.5 million|
|Return on assets TTM||-26.59%|
|Return on equity TTM||-196%|
|Market capitalisation||$203.3 million|
TTM: trailing 12 months
Xeris Pharmaceuticals share dividends
We're not expecting Xeris Pharmaceuticals to pay a dividend over the next 12 months.
Have Xeris Pharmaceuticals's shares ever split?
Xeris Pharmaceuticals's shares were split on 5 October 2021.
Xeris Pharmaceuticals share price volatility
Over the last 12 months, Xeris Pharmaceuticals's shares have ranged in value from as little as $1.25 up to $4.21. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Xeris Pharmaceuticals's is 1.8103. This would suggest that Xeris Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Xeris Pharmaceuticals overview
Xeris Biopharma Holdings, Inc. , a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois. .
Xeris Pharmaceuticals in the news
Are Institutions Heavily Invested In Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shares?
Frequently asked questionsWhat percentage of Xeris Pharmaceuticals is owned by insiders or institutions?
Currently 2.685% of Xeris Pharmaceuticals shares are held by insiders and 42.459% by institutions. How many people work for Xeris Pharmaceuticals?
Latest data suggests 294 work at Xeris Pharmaceuticals. When does the fiscal year end for Xeris Pharmaceuticals?
Xeris Pharmaceuticals's fiscal year ends in December. Where is Xeris Pharmaceuticals based?
Xeris Pharmaceuticals's address is: 180 North LaSalle Street, Chicago, IL, United States, 60601 What is Xeris Pharmaceuticals's ISIN number?
Xeris Pharmaceuticals's international securities identification number is: US98422E1038 What is Xeris Pharmaceuticals's CUSIP number?
Xeris Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 98422L107
More guides on Finder
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert